Royalty Pharma PLC (RPRX)
25.80
+0.10
(+0.37%)
USD |
NASDAQ |
Nov 18, 16:00
25.80
0.00 (0.00%)
After-Hours: 20:00
Royalty Pharma Net Income (Quarterly): 543.99M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 543.99M |
June 30, 2024 | 102.00M |
March 31, 2024 | 4.778M |
December 31, 2023 | 494.34M |
September 30, 2023 | 72.11M |
June 30, 2023 | 227.62M |
March 31, 2023 | 340.76M |
December 31, 2022 | -456.08M |
September 30, 2022 | 142.65M |
June 30, 2022 | 304.50M |
March 31, 2022 | 51.76M |
December 31, 2021 | 7.904M |
Date | Value |
---|---|
September 30, 2021 | 101.93M |
June 30, 2021 | 440.78M |
March 31, 2021 | 69.12M |
December 31, 2020 | 171.09M |
September 30, 2020 | 290.63M |
June 30, 2020 | 442.07M |
March 31, 2020 | 71.24M |
December 31, 2019 | 1.420B |
September 30, 2019 | 408.98M |
June 30, 2019 | 151.71M |
March 31, 2019 | 367.44M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-456.08M
Minimum
Dec 2022
1.420B
Maximum
Dec 2019
242.18M
Average
156.87M
Median
Net Income (Quarterly) Benchmarks
Geron Corp | -26.45M |
Amicus Therapeutics Inc | -6.729M |
Ionis Pharmaceuticals Inc | -140.48M |
Arbutus Biopharma Corp | -19.72M |
Syndax Pharmaceuticals Inc | -84.13M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 564.69M |
Total Expenses (Quarterly) | -170.38M |
EPS Diluted (Quarterly) | 1.21 |
Enterprise Value | 20.65B |
Profit Margin (Quarterly) | 96.33% |
Earnings Yield | 9.89% |
Operating Earnings Yield | 10.04% |
Normalized Earnings Yield | 7.597 |